B. Suresh Kuarm
Researcher
Also affiliated: National Institute of Technology Warangal (2008–2014); Institute of Chemistry (2014); Institute of Chemistry, Academia Sinica (2014)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
B. Suresh Kuarm's research focuses on the synthesis and evaluation of novel chemical compounds for potential therapeutic applications. His work includes the development of thiadiazolidinone (TDZD) analogs, which have demonstrated efficacy in inhibiting aggregation-mediated pathology in neurodegeneration models and extending lifespan in model organisms. Kuarm has also investigated the synthesis of various heterocyclic compounds, such as 1,3,4-selenadiazoles, quinazolinones, and xantheno[2,1-c][1,2,5]selenadiazol-11-one derivatives. These compounds have shown promise as antimicrobial and antitubercular agents. His research publications span areas including drug design, organic synthesis, and medicinal chemistry. Kuarm has a h-index of 15 with 34 publications and 636 citations. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Narsimha Reddy Penthala, Robert J. Shmookler Reis, W. Sue T. Griffin, and Srinivas Ayyadevara.
Metrics
- h-index: 15
- Publications: 34
- Citations: 636
Selected Publications
-
Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan (2023)
Collaboration Network
Top Collaborators
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
- Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
Similar Researchers
Based on overlapping research topics